Hiloprobe

Hiloprobe is a research-based company in the cancer diagnostic field. Hiloprobe is developing ColoNode® – a biomarker test for the accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients.

Hiloprobe joined NOME in 2022 and is headed by Lina Olsson.

Company details

Website

Hiloprobe.se

More companies

Adamant HealthNOME2024-07-09T12:33:39+00:00

Adamant Health
Adamant Health

Medical Devices
Alder TherapeuticsNOME2024-07-09T12:27:31+00:00

Alder Therapeutics
Alder Therapeutics

Therapeutics
CSW TherapeuticsNOME2024-07-09T12:20:00+00:00

CSW Therapeutics
CSW Therapeutics

Medical Devices
Inform LifeNOME2024-07-09T12:35:35+00:00

Inform Life
Inform Life

Other
Reccan DiagnosticsNOME2024-07-09T12:03:38+00:00

Reccan Diagnostics
Reccan Diagnostics

Diagnostics
Fuse VectorsNOME2024-07-09T11:39:06+00:00

Fuse Vectors
Fuse Vectors

Therapeutics
MetsystemNOME2024-05-30T11:11:02+00:00

Metsystem
Metsystem

Digital Health
Droplet IVNOME2024-04-15T08:52:38+00:00

Droplet IV
Droplet IV

Medical Devices

VIEW ALL PROJECTS

Hiloprobe

Project Description

Hiloprobe

Company details

Website

More companies